A recent study reported an association of BMI1 expression to the propensity of metastatic disease in prostate cancer in African-American men [49] and it will be interesting to correlate GSTP1 expression with that of BMI1 in future studies, including how each may contribute to the development of metastatic disease. Here, BMI1 is linked to metastatic neoplasm.